United States Biotechnology & Medical Research

Century Therapeutics Inc (IPSC)

Track

Over the past 90 days, Century Therapeutics Inc. saw eight insider transactions, all of which were sales. Executives Gregory Russotti and Douglas Carr were the primary sellers, resulting in a net negative value of approximately $12,235. These transactions occurred following the company's May 2026 earnings report, where it reported a 24.1% earnings beat.
Ticker: IPSC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Century Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Russotti Gregory
See Remarks
2 sales — total 11,535 USD
Sale 12 Jun 2026
Value US$1,966,921.00 | Price 277.88 | Shares 87,296
Proposed sale 12 Jun 2026
Value US$3,226,039.62 | Price 15.24 | Shares 13,110
Sale 12 Jun 2026
Value US$2,098,316.06 | Price 286.52 | Shares 16,488
Sale 8 Jun 2026
Value US$525.64 | Price 2.11 | Shares 249
Sale 8 Jun 2026
Value US$525.64 | Price 2.11 | Shares 249
Sale 8 Jun 2026
Value US$1,106.16 | Price 2.11 | Shares 524
Proposed sale 8 Jun 2026
Value US$1,106.01 | Price 2.11 | Shares 524
Sale 4 May 2026
Value US$618.02 | Price 2.34 | Shares 264
Sale 12 Mar 2026
Value US$25,683.72 | Price 2.55 | Shares 10,076
Proposed sale 12 Mar 2026
Value US$25,685.74 | Price 2.55 | Shares 10,076
Sale 12 Mar 2026
Value US$17,952.61 | Price 2.55 | Shares 7,043
Sale 9 Mar 2026
Value US$626.39 | Price 2.54 | Shares 247
Sale 9 Mar 2026
Value US$1,214.74 | Price 2.54 | Shares 479
Proposed sale 9 Mar 2026
Value US$1,214.98 | Price 2.54 | Shares 479
Sale 3 Feb 2026
Value US$588.51 | Price 1.82 | Shares 323
Buy 22 Dec 2025
Value US$49,252.30 | Price 0.85 | Shares 58,060
Buy 12 Dec 2025
Value US$30,352.40 | Price 0.58 | Shares 52,000
Sale 8 Dec 2025
Value US$279.83 | Price 0.53 | Shares 526
Proposed sale 8 Dec 2025
Value US$279.94 | Price 0.53 | Shares 526
Sale 8 Dec 2025
Value US$136.72 | Price 0.53 | Shares 257
Proposed sale 8 Dec 2025
Value US$253.33 | Price 0.53 | Shares 476
Sale 20 Nov 2025
Value US$2,736.46 | Price 0.50 | Shares 5,462
Proposed sale 20 Nov 2025
Value US$2,738.65 | Price 0.50 | Shares 5,462
Buy 19 Nov 2025
Value US$17,328.50 | Price 0.50 | Shares 35,000
Sale 17 Nov 2025
Value US$14,735.02 | Price 0.45 | Shares 32,456
Proposed sale 17 Nov 2025
Value US$14,731.78 | Price 0.45 | Shares 32,456
Sale 3 Nov 2025
Value US$171.11 | Price 0.59 | Shares 292
Sale 8 Sep 2025
Value US$131.50 | Price 0.50 | Shares 263
Sale 8 Sep 2025
Value US$244.00 | Price 0.50 | Shares 488
Proposed sale 8 Sep 2025
Value US$243.95 | Price 0.50 | Shares 488
Sale 8 Sep 2025
Value US$269.50 | Price 0.50 | Shares 539
Proposed sale 8 Sep 2025
Value US$269.45 | Price 0.50 | Shares 539
Proposed sale 18 Aug 2025
Value US$17,521.58 | Price 0.57 | Shares 30,745
Sale 4 Aug 2025
Value US$158.06 | Price 0.53 | Shares 296
Sale 9 Jun 2025
Value US$295.45 | Price 0.62 | Shares 475
Proposed sale 9 Jun 2025
Value US$295.50 | Price 0.62 | Shares 475
Sale 9 Jun 2025
Value US$3,050.29 | Price 0.62 | Shares 4,904
Sale 9 Jun 2025
Value US$343.34 | Price 0.62 | Shares 552
Proposed sale 9 Jun 2025
Value US$343.40 | Price 0.62 | Shares 552
Sale 9 Jun 2025
Value US$327.17 | Price 0.62 | Shares 526
Proposed sale 9 Jun 2025
Value US$327.22 | Price 0.62 | Shares 526
Sale 16 May 2025
Value US$16,135.39 | Price 0.55 | Shares 29,552
Proposed sale 16 May 2025
Value US$16,138.35 | Price 0.55 | Shares 29,552
Sale 5 May 2025
Value US$563.20 | Price 0.55 | Shares 1,024
Proposed sale 5 May 2025
Value US$563.10 | Price 0.55 | Shares 1,024
Sale 5 May 2025
Value US$162.25 | Price 0.55 | Shares 295
Sale 10 Mar 2025
Value US$1,374.52 | Price 0.62 | Shares 2,235
Proposed sale 10 Mar 2025
Value US$1,374.97 | Price 0.62 | Shares 2,235
Sale 10 Mar 2025
Value US$1,450.78 | Price 0.62 | Shares 2,359
Proposed sale 10 Mar 2025
Value US$1,451.26 | Price 0.62 | Shares 2,359
Sale 10 Mar 2025
Value US$762.60 | Price 0.62 | Shares 1,240
Sale 10 Mar 2025
Value US$1,451.40 | Price 0.62 | Shares 2,360
Proposed sale 10 Mar 2025
Value US$1,451.87 | Price 0.62 | Shares 2,360
Sale 18 Feb 2025
Value US$27,179.50 | Price 0.78 | Shares 34,712
Proposed sale 18 Feb 2025
Value US$27,165.61 | Price 0.78 | Shares 34,712
Sale 3 Feb 2025
Value US$273.78 | Price 0.78 | Shares 351
Sale 3 Feb 2025
Value US$822.12 | Price 0.78 | Shares 1,054
Proposed sale 3 Feb 2025
Value US$822.54 | Price 0.78 | Shares 1,054
Sale 4 Nov 2024
Value US$1,267.49 | Price 1.23 | Shares 1,033
Proposed sale 4 Nov 2024
Value US$1,267.70 | Price 1.23 | Shares 1,033
Sale 4 Nov 2024
Value US$347.24 | Price 1.23 | Shares 283
Buy 12 Sep 2024
Value US$7,657.00 | Price 1.53 | Shares 5,000
Sale 5 Aug 2024
Value US$1,960.37 | Price 1.83 | Shares 1,073
Proposed sale 5 Aug 2024
Value US$1,960.05 | Price 1.83 | Shares 1,073
Sale 5 Aug 2024
Value US$528.00 | Price 1.83 | Shares 289
Planned sale 26 Jul 2024
Value US$1,465.00 | Price 2.50 | Shares 586
Proposed sale 26 Jul 2024
Value US$1,465.00 | Price 2.50 | Shares 586
Planned sale 24 Jul 2024
Value US$4,029.44 | Price 2.52 | Shares 1,600
Proposed sale 24 Jul 2024
Value US$4,029.50 | Price 2.52 | Shares 1,600
Planned sale 23 Jul 2024
Value US$500.00 | Price 2.50 | Shares 200
Proposed sale 23 Jul 2024
Value US$500.00 | Price 2.50 | Shares 200
Planned sale 20 Jun 2024
Value US$14,178.50 | Price 2.84 | Shares 5,000
Proposed sale 20 Jun 2024
Value US$14,178.45 | Price 2.84 | Shares 5,000
Planned sale 5 Jun 2024
Value US$14,989.00 | Price 3.00 | Shares 5,000
Proposed sale 5 Jun 2024
Value US$14,988.80 | Price 3.00 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 S Sale
3.7
Russotti Gregory

See Remarks

Officer
87,296 +21.6%
277.88
US$1,966,921 		87,296 +21.6% 277.88 US$1,966,921
2026-06-15 2026-06-12 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
16,488 +24.1%
286.52
US$2,098,316 		16,488 +24.1% 286.52 US$2,098,316
2026-06-12 2026-06-12 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
13,110
15.24
US$3,226,040 		13,110 15.24 US$3,226,040
2026-06-09 2026-06-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
249 -0.0%
2.11
US$526 		249 -0.0% 2.11 US$526
2026-06-09 2026-06-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
249 -0.0%
2.11
US$526 		249 -0.0% 2.11 US$526
2026-06-09 2026-06-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
524 -0.1%
2.11
US$1,106 		524 -0.1% 2.11 US$1,106
2026-06-08 2026-06-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
524
2.11
US$1,106 		524 2.11 US$1,106
2026-05-06 2026-05-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
264 -0.1%
2.34
US$618 		264 -0.1% 2.34 US$618
2026-03-16 2026-03-12 S Sale
3.7
Russotti Gregory

See Remarks

Officer
10,076 -1.9%
2.55
US$25,684 		10,076 -1.9% 2.55 US$25,684
2026-03-16 2026-03-12 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
7,043 -1.4%
2.55
US$17,953 		7,043 -1.4% 2.55 US$17,953
2026-03-12 2026-03-12 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
10,076
2.55
US$25,686 		10,076 2.55 US$25,686
2026-03-11 2026-03-09 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
247 -0.0%
2.54
US$626 		247 -0.0% 2.54 US$626
2026-03-11 2026-03-09 S Sale
3.7
Russotti Gregory

See Remarks

Officer
479 -0.1%
2.54
US$1,215 		479 -0.1% 2.54 US$1,215
2026-03-09 2026-03-09 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
479
2.54
US$1,215 		479 2.54 US$1,215
2026-02-05 2026-02-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
323 -0.1%
1.82
US$589 		323 -0.1% 1.82 US$589
2025-12-29 2025-12-22 B Purchase
3.5
Cowan Chad

Chief Scientific Officer

Officer
58,060 +5.9%
0.85
US$49,252 		58,060 +5.9% 0.85 US$49,252
2025-12-16 2025-12-12 B Purchase
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
52,000 +1.6%
0.58
US$30,352 		52,000 +1.6% 0.58 US$30,352
2025-12-10 2025-12-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
526 -0.1%
0.53
US$280 		526 -0.1% 0.53 US$280
2025-12-10 2025-12-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
257 -0.1%
0.53
US$137 		257 -0.1% 0.53 US$137
2025-12-08 2025-12-08 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
476
0.53
US$253 		476 0.53 US$253
2025-12-08 2025-12-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
526
0.53
US$280 		526 0.53 US$280
2025-11-24 2025-11-20 S Sale
3.5
Cowan Chad

Chief Scientific Officer

Officer
5,462 -0.6%
0.50
US$2,736 		5,462 -0.6% 0.50 US$2,736
2025-11-20 2025-11-20 PrS Proposed sale
3.5
Cowan Chad

Officer

Officer
5,462
0.50
US$2,739 		5,462 0.50 US$2,739
2025-11-20 2025-11-19 B Purchase
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
35,000 +1.1%
0.50
US$17,328 		35,000 +1.1% 0.50 US$17,328
2025-11-19 2025-11-17 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
32,456 -1.0%
0.45
US$14,735 		32,456 -1.0% 0.45 US$14,735
2025-11-17 2025-11-17 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
32,456
0.45
US$14,732 		32,456 0.45 US$14,732
2025-11-05 2025-11-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
292 -0.1%
0.59
US$171 		292 -0.1% 0.59 US$171
2025-09-10 2025-09-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
263 -0.1%
0.50
US$132 		263 -0.1% 0.50 US$132
2025-09-10 2025-09-08 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
488 -0.0%
0.50
US$244 		488 -0.0% 0.50 US$244
2025-09-10 2025-09-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
539 -0.1%
0.50
US$270 		539 -0.1% 0.50 US$270
2025-09-08 2025-09-08 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
488
0.50
US$244 		488 0.50 US$244
2025-09-08 2025-09-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
539
0.50
US$269 		539 0.50 US$269
2025-08-18 2025-08-18 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
30,745
0.57
US$17,522 		30,745 0.57 US$17,522
2025-08-06 2025-08-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
296 -0.1%
0.53
US$158 		296 -0.1% 0.53 US$158
2025-06-11 2025-06-09 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
475 -0.0%
0.62
US$295 		475 -0.0% 0.62 US$295
2025-06-11 2025-06-09 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
4,904 -1.2%
0.62
US$3,050 		4,904 -1.2% 0.62 US$3,050
2025-06-11 2025-06-09 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
552 -0.2%
0.62
US$343 		552 -0.2% 0.62 US$343
2025-06-11 2025-06-09 S Sale
3.7
Russotti Gregory

See Remarks

Officer
526 -0.1%
0.62
US$327 		526 -0.1% 0.62 US$327
2025-06-09 2025-06-09 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
475
0.62
US$296 		475 0.62 US$296
2025-06-09 2025-06-09 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
552
0.62
US$343 		552 0.62 US$343
2025-06-09 2025-06-09 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
526
0.62
US$327 		526 0.62 US$327
2025-05-20 2025-05-16 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
29,552 -1.7%
0.55
US$16,135 		29,552 -1.7% 0.55 US$16,135
2025-05-16 2025-05-16 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
29,552
0.55
US$16,138 		29,552 0.55 US$16,138
2025-05-07 2025-05-05 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,024 -0.4%
0.55
US$563 		1,024 -0.4% 0.55 US$563
2025-05-07 2025-05-05 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
295 -0.1%
0.55
US$162 		295 -0.1% 0.55 US$162
2025-05-05 2025-05-05 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,024
0.55
US$563 		1,024 0.55 US$563
2025-03-12 2025-03-10 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
2,235 -0.2%
0.62
US$1,375 		2,235 -0.2% 0.62 US$1,375
2025-03-12 2025-03-10 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
2,359 -1.8%
0.62
US$1,451 		2,359 -1.8% 0.62 US$1,451
2025-03-12 2025-03-10 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
1,240 -0.4%
0.62
US$763 		1,240 -0.4% 0.62 US$763
2025-03-12 2025-03-10 S Sale
3.7
Russotti Gregory

See Remarks

Officer
2,360 -0.9%
0.62
US$1,451 		2,360 -0.9% 0.62 US$1,451
2025-03-10 2025-03-10 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
2,235
0.62
US$1,375 		2,235 0.62 US$1,375
2025-03-10 2025-03-10 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
2,360
0.62
US$1,452 		2,360 0.62 US$1,452
2025-03-10 2025-03-10 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
2,359
0.62
US$1,451 		2,359 0.62 US$1,451
2025-02-20 2025-02-18 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
34,712 -2.8%
0.78
US$27,179 		34,712 -2.8% 0.78 US$27,179
2025-02-18 2025-02-18 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
34,712
0.78
US$27,166 		34,712 0.78 US$27,166
2025-02-05 2025-02-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
351 -0.1%
0.78
US$274 		351 -0.1% 0.78 US$274
2025-02-05 2025-02-03 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,054 -0.8%
0.78
US$822 		1,054 -0.8% 0.78 US$822
2025-02-03 2025-02-03 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,054
0.78
US$823 		1,054 0.78 US$823
2024-11-05 2024-11-04 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,033 -0.8%
1.23
US$1,267 		1,033 -0.8% 1.23 US$1,267
2024-11-05 2024-11-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
283 -0.1%
1.23
US$347 		283 -0.1% 1.23 US$347
2024-11-04 2024-11-04 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,033
1.23
US$1,268 		1,033 1.23 US$1,268
2024-09-16 2024-09-12 B Purchase
2.1
Quimi Daphne
Non-Executive Director
5,000 +inf%
1.53
US$7,657 		5,000 +inf% 1.53 US$7,657
2024-08-07 2024-08-05 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,073 -0.8%
1.83
US$1,960 		1,073 -0.8% 1.83 US$1,960
2024-08-07 2024-08-05 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
289 -0.1%
1.83
US$528 		289 -0.1% 1.83 US$528
2024-08-05 2024-08-05 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,073
1.83
US$1,960 		1,073 1.83 US$1,960
2024-07-31 2024-07-26 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
586 -0.2%
2.50
US$1,465 		586 -0.2% 2.50 US$1,465
2024-07-26 2024-07-26 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
586
2.50
US$1,465 		586 2.50 US$1,465
2024-07-25 2024-07-24 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
1,600 -0.6%
2.52
US$4,029 		1,600 -0.6% 2.52 US$4,029
2024-07-24 2024-07-24 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
1,600
2.52
US$4,030 		1,600 2.52 US$4,030
2024-07-25 2024-07-23 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
200 -0.1%
2.50
US$500 		200 -0.1% 2.50 US$500
2024-07-23 2024-07-23 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
200
2.50
US$500 		200 2.50 US$500
2024-06-24 2024-06-20 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
5,000 -1.8%
2.84
US$14,178 		5,000 -1.8% 2.84 US$14,178
2024-06-20 2024-06-20 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
5,000
2.84
US$14,178 		5,000 2.84 US$14,178
2024-06-06 2024-06-05 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
5,000 -1.7%
3.00
US$14,989 		5,000 -1.7% 3.00 US$14,989
2024-06-05 2024-06-05 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
5,000
3.00
US$14,989 		5,000 3.00 US$14,989
Explore more

More insider trading research around Century Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America